Sujan Dilly Penchala

Author

University of Liverpool ORCID

Also Known As

David Back, S. Dilly Penchala, Sujan D Penchala, Sujan D. Penchala, Sujan Dilly Penchala

Publications

545

Citations

H-Index

Concepts

All Affiliations

University of Liverpool University of Nebraska Medical Center Imperial College London Northwestern University Makerere University

About

Sujan Dilly Penchala is an author at University of Liverpool specializing in medicine, pharmacology, and drug analysis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	227
2	Immunology	3	3	73
3	Engineering	1	1	13
4	Biomedical Engineering	1	1	15
5	Biomolecular Engineering	1	1	13

Sujan Dilly Penchala

Publications

467

Citations

H-Index

Page 1

	Year	Citations
Unintended Pregnancies Observed With Combined Use of the Levonorgestrel Contraceptive Implant and Efavirenz-based Antiretroviral Therapy: A Three-Arm Pharmacokinetic Evaluation Over 48 Weeks Kimberly K. Scarsi, Kristin M. Darin, Shadia Nakalema, Clinical Infectious Diseases	2015	87
The development and validation of a novel LC-MS/MS method for the simultaneous quantification of Molnupiravir and its metabolite ß-d-N4-hydroxycytidine in human plasma and saliva Alieu Amara, Sujan Dilly Penchala, Laura Else, Journal of Pharmaceutical and Biomedical Analysis MedicineBioanalysisAntiviral Drug DevelopmentAntiviral TherapyVirology	2021	79
The development and application of a novel LC–MS/MS method for the measurement of Dolutegravir, Elvitegravir and Cobicistat in human plasma Sujan Dilly Penchala, Sandra Fawcett, Laura Else, Journal of Chromatography B MedicineNovel Lc–ms/ms MethodMass SpectrometryImmunologyHuman Plasma	2016	40
A Validated Method for Quantification of Dolutegravir Using Ultra Performance Liquid Chromatography Coupled With UV Detection Xinzhu Wang, Sujan Dilly Penchala, Alieu Amara, Therapeutic Drug Monitoring	2016	26
Validation and clinical application of a method to quantify nevirapine in dried blood spots and dried breast-milk spots Adeniyi Olagunju, Alieu Amara, Catriona Waitt, Journal of Antimicrobial Chemotherapy	2015	25
A UPLC–MS/MS method for the simultaneous plasma quantification of all isomeric forms of the new anti-HCV protease inhibitors boceprevir and telaprevir Antonio D’Avolio, Amedeo De Nicolò, Danilo Agnesod, Journal of Pharmaceutical and Biomedical Analysis MedicineSimultaneous Plasma QuantificationUplc–ms/ms MethodAntiviral Drug DevelopmentHepatitis	2013	25
Efavirenz‐ but not nevirapine‐based antiretroviral therapy decreases exposure to the levonorgestrel released from a sub‐dermal contraceptive implant Kimberly K. Scarsi, Mohammed Lamorde, Kristin M. Darin, Journal of the International AIDS Society	2014	24
Ceftriaxone pharmacokinetics by a sensitive and simple LC–MS/MS method: Development and application Laura Herrera‐Hidalgo, María Victoria Gil-Navarro, Sujan Dilly Penchala, Journal of Pharmaceutical and Biomedical Analysis Therapeutic Drug MonitoringMedicineSimple Lc–ms/ms MethodDrug MonitoringPharmacotherapy	2020	22
Dose finding study for on-demand HIV pre-exposure prophylaxis for insertive sex in sub-Saharan Africa: results from the CHAPS open label randomised controlled trial Carolina Herrera, Jennifer Serwanga, Laura Else, EBioMedicine	2023	20
Evidence of HIV pre-exposure or post-exposure prophylaxis (PrEP/PEP) among blood donors: a pilot study, England June 2018 to July 2019 Heli Harvala, Claire Reynolds, Samreen Ijaz, Sexually Transmitted Infections	2021	18

Page 1